drugset

drugset / Trial / NCT01944059

Theramine® in the Prevention of Migraine Headache

NCT01944059 ↗

Phase 4 Terminated 31 enrolled Vincent Martin, MD Targeted Medical Pharma · collab

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy of Theramine® as a preventative for migraine headaches.

Timeline

Start: 2013-11
Primary completion: 2014-12
Completion: 2015-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Theramine	Other / unclassified	—	—

Indications